Abstract
1. An inflammation model developed in other laboratories was used in this study. Mice given endotoxin intranasally developed lung inflammation which progresses in intensity for several days. Lung weight is a satisfactory measure of inflammation.
2. In lungs of mice treated intranasally with endotoxin, histidine decarboxylase was activated within 6 hr, before lung weight had increased substantially. Enzyme activity was near maximal at 24 hr but had dropped by 48 hr, at which time inflammation was increasing. The data are consistent with an early role for histamine in mediating inflammation, but not with an essential role in the later stages.
3. When actinomycin D, an inhibitor of RNA synthesis, was mixed with endotoxin solution and given to mice intranasally, both lung inflammation and histidine decarboxylase activation were markedly enhanced at 24 and 48 hr, relative to effects produced by endotoxin alone.
4. Evidence is presented that intranasal instillation of endotoxin into mice increases histamine formation in lung in vivo.
5. We previously found protein synthesis inhibitors, the only drugs shown capable of blocking histidine decarboxylase activation, to be powerful anti-inflammatory agents. Now we have found that actinomycin D, the only drug shown capable of enhancing histidine decarboxylase activation, to be strongly pro-inflammatory. These observations support a causative role for histamine in slowly-developing inflammation, and also provide a rigorous test for the participation of other mediator candidates.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- DOUGHERTY R. M., GROUPE V., MANAKER R. A. Comparative effects of hydrocortisone, a derived pyridopyrimidine, and xerosin on pneumonia produced in mice by viral and bacterial toxin. J Bacteriol. 1956 Nov;72(5):604–609. doi: 10.1128/jb.72.5.604-609.1956. [DOI] [PMC free article] [PubMed] [Google Scholar]
- GINSBERG H. S. Suppression of influenza viral pneumonia in mice by the non-specific action of xerosin. J Immunol. 1955 Dec;75(6):430–440. [PubMed] [Google Scholar]
- Reilly M. A., Schayer R. W. Further studies on the histidine-histamine relationship in vivo: effects of endotoxin and of histidine decarboxylase inhibitors. Br J Pharmacol. 1968 Nov;34(3):551–563. doi: 10.1111/j.1476-5381.1968.tb08484.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Reilly M. A., Schayer R. W. Studies on the histidine-histamine relationship in vivo. Br J Pharmacol Chemother. 1968 Mar;32(3):567–574. doi: 10.1111/j.1476-5381.1968.tb00456.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- SCHAYER R. W. Evidence that induced histamine is an intrinsic regulator of the microcirculatory system. Am J Physiol. 1962 Jan;202:66–72. doi: 10.1152/ajplegacy.1962.202.1.66. [DOI] [PubMed] [Google Scholar]
- Schayer R. W. Determination of histidine decarboxylase activity. Methods Biochem Anal. 1968;16:273–291. doi: 10.1002/9780470110348.ch5. [DOI] [PubMed] [Google Scholar]
- Schayer R. W. Evidence for inactivation of colloidal irritants by mouseliver in vivo. J Reticuloendothel Soc. 1967 Jan;4(1):1–9. [PubMed] [Google Scholar]
- Schayer R. W., Reilly M. A. Suppression of inflammation and histidine decarboxylase by protein synthesis inhibitors. Am J Physiol. 1968 Aug;215(2):472–476. doi: 10.1152/ajplegacy.1968.215.2.472. [DOI] [PubMed] [Google Scholar]